Tactile Medical appoints Laura King to its Board of Directors, enhancing leadership in chronic disorder therapies.
Quiver AI Summary
Tactile Systems Technology, Inc. has appointed Laura King to its Board of Directors and to the Audit and Compliance & Reimbursement Committees, effective January 13, 2025. Ms. King is an experienced healthcare executive, previously serving as President & CEO of GE Healthcare’s Global Interventional Business, and holds extensive roles in audit and finance at GE. She is currently the co-founder and CEO of BiaCure, Inc., and has a history of leading innovative medical companies, including Elucent Medical and NeuWave Medical. Tactile Medical's Chairman, Bill Burke, expressed enthusiasm for her joining the board, highlighting the potential benefits of her expertise in developing healthcare technologies that enhance patient care as the company focuses on expanding its reach in chronic condition therapies.
Potential Positives
- Appointment of Laura King to the Board of Directors, bringing significant healthcare leadership experience and a proven track record in developing innovative medical technologies.
- Ms. King's background includes leadership roles in GE Healthcare and successful ventures in companies that have positively impacted patient care, aligning with Tactile Medical's mission.
- The expansion of the Board's expertise may enhance Tactile Medical's strategic direction and innovation in therapies for chronic conditions, potentially improving market competitiveness.
Potential Negatives
- Appointment of Laura King may highlight a lack of internal succession planning or leadership depth within Tactile Medical, indicating potential challenges in long-term strategic continuity.
- Ms. King's background as a co-founder of multiple companies may raise concerns about her ability to commit sufficient time and focus on Tactile Medical’s operational needs, particularly during periods of significant business transition or growth.
FAQ
Who is Laura King?
Laura King is a seasoned healthcare executive and the new member of Tactile Medical's Board of Directors.
What role will Laura King have at Tactile Medical?
Laura King will serve on the Audit and Compliance & Reimbursement Committees as a Board member.
What is Tactile Medical known for?
Tactile Medical specializes in at-home therapies for chronic conditions like lymphedema and chronic pulmonary disease.
What are Laura King's previous experiences?
Laura King has held leadership roles at GE Healthcare and co-founded companies like BiaCure and Elucent Medical.
Why is Laura King's appointment significant for Tactile Medical?
Her expertise in healthcare innovation will enhance Tactile Medical's initiatives in patient care and technological development.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$TCMD Congressional Stock Trading
Members of Congress have traded $TCMD stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $TCMD stock by members of Congress over the last 6 months:
- SENATOR TINA SMITH purchased up to $100,000 on 11/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$TCMD Insider Trading Activity
$TCMD insiders have traded $TCMD stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TCMD stock by insiders over the last 6 months:
- SHERRI LEE FERSTLER (Senior VP, Sales) sold 1,550 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TCMD Hedge Fund Activity
We have seen 67 institutional investors add shares of $TCMD stock to their portfolio, and 63 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FIRST LIGHT ASSET MANAGEMENT, LLC removed 1,338,902 shares (-100.0%) from their portfolio in Q3 2024
- PARADIGM CAPITAL MANAGEMENT INC/NY added 481,000 shares (+40.6%) to their portfolio in Q3 2024
- MORGAN STANLEY added 408,980 shares (+21.5%) to their portfolio in Q3 2024
- PINNACLE ASSOCIATES LTD removed 259,741 shares (-81.9%) from their portfolio in Q3 2024
- CADIAN CAPITAL MANAGEMENT, LP removed 186,427 shares (-8.8%) from their portfolio in Q3 2024
- ESSEX INVESTMENT MANAGEMENT CO LLC added 123,401 shares (+inf%) to their portfolio in Q3 2024
- ACCREDITED INVESTORS INC. removed 110,971 shares (-96.2%) from their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company’s Board of Directors (“Board”) and as a member of the Audit and Compliance & Reimbursement Committees, effective January 13, 2025.
Ms. King is a seasoned healthcare executive with a proven track record of leadership and developing innovative products that enhance patient care. Her extensive experience includes a 22-year career at General Electric Company (GE), where she served as a Company Officer in her role as President & CEO of GE Healthcare’s Global Interventional Business, which provided clinical solutions enabling minimally invasive procedures in cardiology, interventional radiology, and surgery. Her earlier experience at GE included various senior level audit and finance roles, including Chief Information Officer & Chief Financial Officer, Consumer & ECM Motors. Ms. King is currently co-founder & CEO of BiaCure, Inc., a developer of effective treatments for nail fungus. Previously, she co-founded and served as CEO of Elucent Medical, a developer of a real-time surgical navigation platform that has positively impacted over 10,000 breast cancer patients. Ms. King also served as President & CEO of NeuWave Medical, a manufacturer and marketer of a minimally invasive soft tissue microwave ablation system to destroy tumor cells, which was acquired by Johnson & Johnson’s MedTech division.
“We are thrilled to have Laura join our Board of Directors,” said Bill Burke, Chairman of the Board of Tactile Medical. “Tactile will benefit from her considerable experience leading healthcare companies that develop innovative technologies to improve patient care as we continue to expand our impact in lymphedema, airway clearance, and other at-home therapies for people with underserved, chronic conditions.”
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
This article was originally published on Quiver News, read the full story.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
